BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$74.84
−0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 835.11x
- P/E 2028E
- 20.07x
- P/S forward
- 11.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.82x
- Price / sales
- 21.15x
- Price / cash flow
- -24.94x
Enterprise value
- Enterprise value
- $16.4B
- EV / sales
- 23.72x
- EV / EBITDA
- -27.23x
- EV / EBIT
- -30.20x
- Market cap
- $14.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026